Mercer Capital Advisers’s GSK GSK Stock Holding History

Mercer Capital Advisers’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-400	Closed	-$19K	–	161
2020 Q3	$19K	Buy	400 +80	+25%	+$4.01K	0.01%	163
2020 Q2	$16K	Hold	320	–	–	0.01%	169
2020 Q1	$15K	Hold	320	–	–	0.01%	165
2019 Q4	$19K	Hold	320	–	–	0.01%	173
2019 Q3	$17K	Hold	320	–	–	0.01%	179
2019 Q2	$16K	Hold	320	–	–	0.01%	183
2019 Q1	$17K	Hold	320	–	–	0.01%	183
2018 Q4	$15K	Hold	320	–	–	0.01%	186
2018 Q3	$16K	Hold	320	–	–	0.01%	193
2018 Q2	$16K	Hold	320	–	–	0.01%	200
2018 Q1	$16K	Hold	320	–	–	0.01%	195
2017 Q4	$14K	Hold	320	–	–	0.01%	198
2017 Q3	$16K	Hold	320	–	–	0.01%	200
2017 Q2	$17K	Hold	320	–	–	0.01%	206
2017 Q1	$17K	Hold	320	–	–	0.01%	207
2016 Q4	$15K	Hold	320	–	–	0.01%	211
2016 Q3	$17K	Hold	320	–	–	0.01%	219
2016 Q2	$17K	Hold	320	–	–	0.01%	214
2016 Q1	$16K	Hold	320	–	–	0.01%	215
2015 Q4	$16K	Hold	320	–	–	0.01%	222
2015 Q3	$15K	Hold	320	–	–	0.01%	220
2015 Q2	$17K	Hold	320	–	–	0.02%	229
2015 Q1	$18K	Buy	320 +80	+33%	+$4.59K	0.02%	221
2014 Q4	$13K	Buy	+240	New	+$13.4K	0.01%	235

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Mercer Capital Advisers's GSK Position: Q4 2020 in Review

Mercer Capital Advisers sold out of GSK (GSK) in Q4 2020, closing a stake of 400 shares — an estimated $19K sold.

Mercer Capital Advisers first reported a position in GSK in Q4 2014 and held it in 24 quarters. The position peaked at $19K in Q3 2020. 818 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

Mercer Capital Advisers reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
Mercer Capital Advisers sold 400 GSK shares in Q4 2020, an estimated $19K.
Mercer Capital Advisers first reported a position in GSK in Q4 2014 and held it in 24 quarters.
Mercer Capital Advisers's GSK position peaked at $19K in Q3 2020.
818 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Mercer Capital Advisers's 13F filing for Q4 2020, filed 28 Jan 2021.